Upstream Bio Reports Results for Quarter Ended June 30, 2026

What Happened
Upstream Bio, Inc. (UPB) filed a Current Report on Form 8-K on August 11, 2026 disclosing that it announced its financial results and business highlights for the quarter ended June 30, 2026. The company furnished a press release containing those results as Exhibit 99.1 to the 8-K. The filing was signed by CEO E. Rand Sutherland.

Key Details

• Filing date: August 11, 2026 (Form 8-K, Accession No. 0001193125-26-343407).
• Period covered: quarter ended June 30, 2026.
• Press release with the quarterly results and business highlights is furnished as Exhibit 99.1 to the 8-K.
• Report signed by E. Rand Sutherland, M.D., Chief Executive Officer.

Why It Matters
This 8-K signals that Upstream Bio has issued its latest quarterly results and operational update—information investors use to assess recent revenue, expenses, cash position, and business progress. The 8-K itself references the press release but does not include the detailed financial figures; investors should review Exhibit 99.1 (the press release) or the company’s investor relations materials for the specific earnings, revenue, or guidance data. No management changes or other material corporate actions were reported in this filing.